Profit Or Loss [Abstract]

Innate Pharma - Filing #2821023

Concept 2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
70 451 EUR
85 814 EUR
Profit (loss) from operating activities
62 076 EUR
27 052 EUR
Finance income
4 855 EUR
11 269 EUR
Finance costs
6 763 EUR
4 976 EUR
Profit (loss) before tax
63 984 EUR
20 759 EUR
Tax expense (income)
EUR
EUR
Profit (loss)
63 984 EUR
63 984 EUR
20 759 EUR
20 759 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
81.00
31.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
81.00
31.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.